ID18726A - Melanoma yang disesuaikan analog-analog peptida vaksin-vaksin yang melawan melanoma - Google Patents

Melanoma yang disesuaikan analog-analog peptida vaksin-vaksin yang melawan melanoma

Info

Publication number
ID18726A
ID18726A IDP972391A ID972391A ID18726A ID 18726 A ID18726 A ID 18726A ID P972391 A IDP972391 A ID P972391A ID 972391 A ID972391 A ID 972391A ID 18726 A ID18726 A ID 18726A
Authority
ID
Indonesia
Prior art keywords
melanoma
peptides
vaccines against
ctl
improved immunogenicity
Prior art date
Application number
IDP972391A
Other languages
English (en)
Indonesian (id)
Inventor
Carl Gustav Figdor
Gosse Jan Adema
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of ID18726A publication Critical patent/ID18726A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3053—Skin, nerves, brain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IDP972391A 1996-07-11 1997-07-10 Melanoma yang disesuaikan analog-analog peptida vaksin-vaksin yang melawan melanoma ID18726A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96201945 1996-07-11

Publications (1)

Publication Number Publication Date
ID18726A true ID18726A (id) 1998-05-07

Family

ID=8224171

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP972391A ID18726A (id) 1996-07-11 1997-07-10 Melanoma yang disesuaikan analog-analog peptida vaksin-vaksin yang melawan melanoma

Country Status (10)

Country Link
EP (1) EP0934405B1 (de)
JP (2) JP4386463B2 (de)
AT (1) ATE206759T1 (de)
AU (1) AU3693897A (de)
CA (1) CA2259944C (de)
DE (1) DE69707296T2 (de)
ES (1) ES2165619T3 (de)
ID (1) ID18726A (de)
WO (1) WO1998002538A1 (de)
ZA (1) ZA975858B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA975858B (en) * 1996-07-11 1998-09-01 Akzo Nobel Nv Melanoma associated peptide analogues and vaccines against melanoma
US20040156861A1 (en) 1996-07-11 2004-08-12 Figdor Carl Gustav Melanoma associated peptide analogues and vaccines against melanoma
FR2763071B1 (fr) * 1997-05-07 2003-05-16 Centre Nat Rech Scient Analogues peptidiques, et leurs utilisations notamment dans des compositions pharmaceutiques et pour le diagnostic
EP1012173B1 (de) * 1997-06-23 2007-10-31 Ludwig Institute For Cancer Research Isolierte decapeptide, die an hla moleküle binden, sowie deren verwendung
CA2388301C (en) * 1999-10-22 2011-01-04 Aventis Pasteur Limited Modified gp100 and uses thereof
EP1359937A4 (de) * 2001-02-14 2004-07-28 Genzyme Corp Veränderte peptidliganden
CA2674445C (en) 2007-01-12 2016-06-07 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Gp100-specific t cell receptors and related materials and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2224113T5 (es) * 1994-02-16 2009-05-01 The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services Polipeptido antigenico asociado al melanoma, epitopos del mismo y vacunas contra melanoma.
WO1995029193A2 (en) * 1994-04-22 1995-11-02 The Government Of The United States Of America Represented By The Secretary, Department Of Health And Human Services Melanoma antigens
ZA975858B (en) * 1996-07-11 1998-09-01 Akzo Nobel Nv Melanoma associated peptide analogues and vaccines against melanoma

Also Published As

Publication number Publication date
EP0934405B1 (de) 2001-10-10
CA2259944C (en) 2011-06-28
JP2000515739A (ja) 2000-11-28
DE69707296T2 (de) 2002-07-25
DE69707296D1 (de) 2001-11-15
ATE206759T1 (de) 2001-10-15
CA2259944A1 (en) 1998-01-22
JP4386463B2 (ja) 2009-12-16
JP5198354B2 (ja) 2013-05-15
WO1998002538A1 (en) 1998-01-22
ZA975858B (en) 1998-09-01
JP2009178166A (ja) 2009-08-13
ES2165619T3 (es) 2002-03-16
EP0934405A1 (de) 1999-08-11
AU3693897A (en) 1998-02-09

Similar Documents

Publication Publication Date Title
FI950665A0 (fi) Melanoomaan liittyvä antigeeninen polypeptidi, sen epitooppeja ja melanoomarokotteita
HU9500571D0 (en) Retro-, inverso-, and retro-inverso synthetic peptide analogues
ZA9510832B (en) Variants of human papilloma virus antigens
IL141868A0 (en) Novel methods for therapeutic vaccination
NO994983D0 (no) Fremgangsmåte for fremstilling av anti-humane antigenreseptorer, samt anvendelse av disse
WO2006014579A3 (en) Enhancing class i antigen presentation with synthetic sequences
CO4810234A1 (es) Vacunas para el tratamiento de virus papiloma humano
CY1107706T1 (el) Πεπτιδια ανταγωνιστες καρκινοεμβρυονικου αντιγονου (cea)
MX2023004465A (es) Composiciones basadas en virus y métodos para redirigir respuestas inmunitarias preexistentes mediante su uso para el tratamiento del cáncer.
DE69638024D1 (de) Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren
ZA975858B (en) Melanoma associated peptide analogues and vaccines against melanoma
GB2220939B (en) Peptide fragments of hiv and their use in vaccines and diagnosis
AU2003241127A8 (en) Membrane-anchored beta2 microglobulin covalently linked to mhc class i peptide epitopes
EP2193804A3 (de) Rekombinantes Adenylat-Cyclase-Toxin von Bordetella induziert T-Zell-Antworten gegen tumorale Antigene
WO2000012122A3 (de) Niedermolekulare fragmente der hyaluronsäure zur herstellung von impfstoffen
OA09653A (en) Rubella peptides
NZ515332A (en) Lawsonia derived gene and related SodC polypeptides, peptides and proteins and their uses
ATE482974T1 (de) Multimere peptide, die auf dem hepatitis c virus hüllprotein basieren, für diagnostische verwendung und für impfzwecke
DE69637435D1 (de) Saponin-zusammensetzungen und deren verwendung
SE8700466D0 (sv) Vaccines against melanoma
EP1020516A3 (de) Impfstoff-Antigene von Leptospira zur Vermeidung von Leptospirosis
Berzofsky Progress toward an artificial vaccine for HIV: identification of helper and cytotoxic T-cell epitopes and methods of immunization.
EP1502602A3 (de) Verfahren zur therapeutischen Impfung
YU24401A (sh) Novi postupci za terapeutsku vakcinaciju
PT1560848E (pt) Péptido imunogénico de ptprk